Eventide ETF’s 2.12% Medtronic Stake Faces Pressure After $550M Acquisition
Eventide Large Cap Value ETF holds 2.12% in Medtronic, whose shares fell over 1% after announcing a $550 million acquisition of Scientia Vascular. Medtronic’s stock is trading 7.7% below its 20-day SMA and carries a 29.66 RSI, suggesting mixed momentum for the ETF’s holdings.
1. ETF Exposure to Medtronic
Eventide Large Cap Value ETF holds 2.12% in Medtronic, ranking it among the fund’s top positions. This concentration links ETF performance directly to Medtronic’s operational developments and share price movements.
2. Acquisition of Scientia Vascular
On March 10, Medtronic agreed to acquire Scientia Vascular for $550 million, with undisclosed earn-out and milestone payments possible. The deal will fold the private company’s 310 employees and its guidewires and catheters into Medtronic’s neurovascular portfolio, targeting a first-half fiscal 2027 close.
3. Stock Technicals and ETF Implications
Medtronic shares are trading 7.7% below their 20-day SMA and 8.8% below their 50-day SMA, while an RSI of 29.66 signals oversold conditions. These bearish indicators may weigh on the ETF’s near-term performance but could also hint at a potential rebound if buying pressure returns.